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We conducted a population-based cross-sectional epidemiologic survey of asthma and COPD in
an adult representative national sample using information obtained from the Health Search
Database owned by the Italian College of General Practitioners. General Practitioners who
had a list of patient population of 909,638 individuals (429,962 men and 479,676 women;
man/woman ratio [M/WR]: 0.89) 14 years old at the end of December 2009 were selected
to be representatives of the whole Italian population. Cases of asthma and COPD were identi-
fied on the basis of the ICD-9 codes. The total sample included 55,500 (6.10% of the entire po-
pulation; 5.49% of men and 6.64% of women; M/WR: 0.74) subjects suffering from asthma and
25,762 (2.83% of the entire population; 3.51% of men and 2.23% of women; M/WR: 1.41)
subjects suffering from COPD. The asthma/COPD ratio in general population was 2.16. The
odds ratio (OR) was chosen because asthma and COPD had a prevalence less than 10%. The
OR of developing asthma decreased with age both in men and women, but in the first group
of age (15e34 years) it was higher in men vs. women (1.69 vs. 1.00) although it became lower
than 1 from 35 years old and up in men and from 75 years old and up in women. On the
contrary, the OR of developing COPD became higher than 1 from 55 years old and up both in
men and in women and progressively increased with age (in the group 75e84 years, it was
6.16 in men and 4.07 in women, respectively).
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Asthma and COPD are common chronic diseases of the
airways that are mainly diagnosed and treated in general
practice. The general practitioner (GP) is the provider of
basic medical care and is the gateway to specialized care.
Therefore, it is important that the GPs know the prevalence
of different diseases in their practice.
In Italy, national statistics on morbidity are based on self-
reported information, and only few researchers have inves-
tigated whether some differences might arise when using
data from Health Interview Surveys and from medical
records.1 Unfortunately, the self-reported prevalence of
asthma or COPD, when compared with GP registration, is
associated with an overestimation in people who suffer from
other respiratory conditions and with an underestimation in
elderly persons living in a smoky environmentwho have fewer
chronic diseases.2
The aim of this study was to epidemiologically investigate
the prevalence and risk of asthma and COPD in Italy using
medical records obtained from the Health Search Database
(HSD) owned by the Italian College of General Practitioners
(SIMG), which stores information on about 1.5% of the total
Italian population served by general practitioners (GPs).
Material and methods
We conducted an adult population-based cross-sectional
epidemiologic survey of asthma and COPD in a representative
national sample using information obtained from the HSD.
The software system used codes all the diagnostic records
utilizing the International Classification of Diseases (9th
revision: ICD-9).3 The participating GPs use the same software
to record data during their daily practice, and they agree to
send periodically complete, but anonymous, records of their
patients to the HSD. A unique patient code links demographic
and prescription information, clinical events and diagnoses,
hospital admission, and cause of death. It is well known that
before using any data resource, particularly one that is based
on computer records, it is necessary to determine the quality
and completeness of the available information. Therefore,
data are subject to a range of quality checks. Any variations
within agreed ranges are investigated and submitted to each
participating GP. Physicians who fail to meet standard quality
criteria are not considered for epidemiological studies.4
700 GPs, who had a list of patient population of 909,638
individuals (429,962 men and 479,676 women; man/woman
ratio [M/WR]: 0.89) older than 14 years at the end of
December 2009, were selected to be representatives of the
whole Italian population and also because they ensured the
required data quality.
Since the study was a retrospective analysis of data
already available in the HSD, and confidentiality of patients
was in noway violated, local rules do not request approval by
an ethics committee.
Ascertainment of COPD and asthma
Cases of COPD were identified on the basis of the ICD-9 codes
491, 492, and 496, and those of asthmaon the basis of the ICD-
9 code 493.Analysis
The study was carried out by a cross-sectional and observa-
tional field method. It permitted to describe the situation at
the timeof data collection, at theendofDecember 2009, and
it allowed determining the prevalence of investigated
outcomes. Furthermore, we evaluated the risk factor (RF)
calculating the OR or RR. In order to investigate the associ-
ation between variables, it was chosen to use OR instead of
RRbecause the diseases of the study (asthmaandCOPD) have
a relatively low prevalence that is less than 10%. Positive and
negative OR values mean a co-relative positive and negative
association between evaluated variables.5,6
This epidemiological study had a confidence level of
99.99% (setting the hypothesized % frequency of outcome
factor in the population at 50% and confidence limit of 0.2%).
The studied population was divided by several clusters:
disease, age (15e34, 35e44, 45e54, 55e64, 65e74, 75e84
and older than 85 years old), and gender (male and female).
In order to calculate statistical and epidemiological
values, computer software GraphPad Prism (CA, USA) and
OpenEpi (Dean AG, Sullivan KM, Soe MM. Open Source
Epidemiologic Statistics for Public Health) were used.Results
The total sample included 55,500 (6.10% of the entire
population; 5.49% of men and 6.64% of women; M/WR:0.74)
subjects suffering from asthma and 25,762 (2.83% of the
entire population; 3.51% of men and 2.23% of women; M/
WR:1.41) subjects suffering from COPD. The asthma/COPD
ratio in general population was 2.16 (Table 1).
The prevalence of these diseases by age cluster is shown
in Fig. 1. In asthma, it was higher in women in all age
clusters except in the 15e34 group. In COPD, the preva-
lence was higher in men in all age clusters, with a marked
difference between sexes after 64 years of age.
The OR of developing asthma decreased with age both in
men and women, but in the first group of age (15e34 years)
it was higher in men vs. women (1.69 vs.1.00) although it
became lower than 1 from 35 years old and up in men and
from 75 years onwards in women. On the contrary, the OR
of developing COPD became higher than 1 from 55 years old
and up both in men and in women and progressively
increased with age (in the group 75e84 years, it was 6.16 in
men and 4.07 in women, respectively) (Fig. 2).
In Fig. 3 we report the prevalence of smoking habit in
the general Italian population using data recorded by the
Italian Central Institute of Statistics (ISTAT). These data
show that in asthmatic patients smoking does not play
a role, whereas, as expected, in COPD there is an important
correlation between smoking and disease.Discussion
The first important finding of our study is the documenta-
tion that the asthma/COPD ratio in our population was
2.16, with a prevalence of asthma and COPD of 6.10% and
2.83%, respectively. We must highlight that the prevalence
of asthma in our study was very well in line with results
Table 1 Prevalence (%) and rates of asthma and COPD in population study by gender cluster.
Prevalence (%) Rates
Female Male Total Male/female Asthma/COPD female Asthma/COPD male Asthma/COPD total
Asthma 6.64 5.49 6.10 0.83 2.98 1.56 2.16
COPD 2.23 3.51 2.83 1.57
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general population. This is not very common in register
studies, as they normally results in underestimations.
Therefore, we believe that this is a strength of our study
and of the usefulness of the HSD.
We cannot deny that there may have been misclassifica-
tion when our GPs have used specific diagnostic categories.
Despite the availability of consensus guideline diagnostic
recommendations, diagnostic confusion between COPD and
asthma appears common in primary care patients.7 The
FinEsS-study assessed whether differences existed in preva-
lence of asthma, chronic bronchitis, and respiratory symp-
toms between three Baltic capitals, and examined the risk
factor profiles for respiratory conditions.8 Prevalence of
respiratory symptomswas higher in Tallinn than in Stockholm
and Helsinki, while physician-diagnosed asthma was more
common in Stockholm and Helsinki and the prevalence of
physician-diagnosed chronic bronchitis was three times as
high inTallinnas inHelsinki or Stockholm. It is likely that these
considerable differences in prevalence rates of physician-
diagnosed asthma and COPD were due to substantial differ-
ence in diagnostic practices between the three countries,
while thedifferences between thecapitals in trueprevalence
of disease was small.
In general, COPD is underestimated by GPs. In a pop-
ulation-based study in which COPD was diagnosed based on
the assessment of lung function by means of spirometry, the
so called Burden Of Obstructive Lung Disease (BOLD) study,
prevalences between 8.2 and 19.1% in adults 40 years of age
or older were found.9 In primary care, much lower estimates
of the prevalence of physician-diagnosed COPD have beenFig. 1 Cases of asthma and COPD in the studied Italian populat
COPD by age and gender clusters.reported (between 1.5 and 3%).10e12 However, we must
stress that the BOLD study included also mild COPD (which
comprise approximately a half of the COPD-cases) with the
diagnosis based only on the FEV1/FVC ratio< 0.7
9 and they
could have a normal FEV1, so it is not surprising that all these
mild COPD cases not are identified by the health care system.
On the other hand, some studies found an overdiagnosis of
asthma in primary health care.13,14 In particular, Aaron and
colleagues recently found that about one-third of obese and
nonobese individuals with physician-diagnosed asthma had
no evidence of asthmawhen their medications were tapered
and when they were evaluated with serial assessments of
symptoms, lung function and bronchial challenge tests.15 We
recognize that GPs are faced with an array of alternative
codes for the same or similar conditions. In effect, practicing
physicians have little faith in the accuracy of the ICD-9
diagnoses entered for prescription purposes and this can
question the real value of diagnoses in the HSD, including
that of COPD and asthma. It is plausible that misdiagnosis,
including possible gender bias, could be reduced by the
appropriate use of objective laboratory studies. Unfortu-
nately, previously, it was shown that Italian GPs make little
use of spirometry in their investigation of chronic respiratory
symptoms.16
In the majority of our patients, the diagnosis of asthma or
COPD was mainly clinical and this can be interpreted as
a severe limitation. In 2004, Viegi and colleagues17 analyzed
data from two prospective studies (4353 subjects who had
acceptable FVC test results) carried out in Italy, in the rural
area of Po River delta from1988 to 1991 and in the urban area
of Pisa from 1991 to 1993. Prevalence rates of asthma,ion. Points shown represent the prevalence (%) of asthma and
Fig. 2 Risk factors of asthma and COPD. Points shown represent odds ratios and 95% confidence limits of associations between
risk of asthma and COPD and age and gender. Values >1 indicate a positive association and values <1 indicate negative association,
DP< 0.05 vs. non-exposed population.
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1.2% in the Po delta, and 6.5%, 2.5%, and 3.6% in Pisa. For
both genders, the frequency of isolated asthma decreased
with age, while that of isolated airflow obstruction, chronic
bronchitis-emphysema, and the combination of asthma and
chronic bronchitis-emphysema increased. It is difficult to
compare the results of that study and our results, since there
are considerable differences in the methods used and the
study populations included. In particular, our analysis was
restricted to those patients who consulted their GPs.
Therefore, the conclusions of our study are probably not
valid for the healthiest people: those who did not consult
their GPs at all. Nonetheless, our research, using a larger
population with a different approach, confirmed that the
prevalence of asthma was higher than that of COPD and,
moreover, age was a strong and positive risk factor of COPD,
whereas in asthma the correlation between disease and age
was weakly negative.
Similarities in the conclusions of our study and those of
Viegi and colleagues17 are important considering that it has
been highlighted that distinction between COPD and asthma
may be relatively easy in patients with severe disease or inFig. 3 Prevalence (%, A) and correlation (rate, B and C) of smokin
>0 indicate a positive correlation and values <0 indicate negative
obtained from the Italian Statistical Yearbook 2009 of Italian Centraolder patients, but in many cases it is not so clear as clinical
signs and symptoms show overlap. This is particularly the
case in family practice, where the diagnostic process is
primarily based on symptoms and signs presented by the
patient.18 In any case, it must be mentioned that only
25e50% of asthma or COPD patients are known to their
doctor.19 In fact, it seems that the majority of patients with
a decreased FEV1 do not complain of any bronchial symp-
toms.20 Poor perception of dyspnoea is a probable cause of
underpresentation by patients, so neither the physician nor
the patient is to blame for the underdiagnosis of asthma or
COPD in the general population.10
Our data confirm that young adults are at highest risk of
having a diagnosis of asthma. In the current study, the
prevalence was highest in the age group of 15e34 years old
(physician-diagnosed asthma 7.19%) and declined progres-
sively to become 4.12 in the cluster of age >85 years old.
However, the decrease in prevalence was progressive in
men, but women showed an increase in prevalence up to the
cluster of age 45e54 years old and soon after a progressive
decrease, although the prevalence remained always higher
in women than in men. This last finding contrasts withg habit and asthma or COPD by gender clusters. B and C: values
correlation. Smoking habit data of general population (A) were
l Institute of Statistic (ISTAT), available at http://www.istat.it.
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current asthma was more prevalent in men than women
(5.1% compared to 1.8%).21 Also a cross-sectional French
study documented that in men, the prevalence rate was
higher that in women (7.3% for cumulative asthma and 2.8%
for current asthma vs. 5.2% and 2.2%, respectively). In any
case, as in our study, the rates were lower at advanced ages
(>85 years) for both men and women.22
Consistent with the international epidemiology of COPD,9
a progressive rise of prevalence with age in both sexes until
the age of 84 years was observed. The prevalence was higher
inmen than inwomen. For those aged 75 years and older, the
prevalencewas 14.15% formen and 6.61% for women. Report
from the Obstructive Lung Disease in Northern Sweden
(OLIN) Studies confirms that increasing age, together with
smoking, is the dominating risk factor for COPD.23
In our study, male gender was a risk factor of asthma
only in young people, being the ORs in men always lower
than 1 from 35 years old and up. This finding contrasts with
the documentation in the “Pollution Atmospherique et
Affections Respiratoires” (PAARC) study that, from aged 50
yrs upwards rates in men increased.24 On the contrary, in
our study female gender was a significant risk factor only in
the age group 45e54 years, with an OR that was 1.11. From
75 years old and up, the ORs were lower than 1 also in
women. Our results differ from those reported by Osman
and colleagues25 documenting a higher prevalence of
asthma in women from 15 years old and up. The timing of
the gender reversal in asthma prevalence has generally
been reported to occur between 10 and 20 years of age in
most studies, with exceptions locating the switch beyond
20 years.26 However they fit with other Italian reports. The
prevalence of an “episode of asthma” (defined as a self-
reported attack of asthma or treatment for asthma) and of
“current asthma” (defined as a self-reported attack of
asthma, treatment for asthma or wheezing other than due
to a cold with dyspnoea in the last 12 months) was 3.47%
(3.74% in men and 3.14% in women) and 5.01% (5.07% in
men and 4.90% in women), respectively, in randomly
selected subjects, aged 20e44 years, living in three areas
of northern Italy: Turin, Pavia, and Verona.27 Interestingly,
no differences were found on the basis of age and sex. In
a French survey, asthma was inversely correlated to age
(higher prevalence in the youngest) but was not related to
sex.28 Nonetheless, it is important to highlight that an
analysis based on a total of 9,486,173 hospital records in
Canada for a 3-year period, including 204,304 asthma
patients and 288,977 asthma-related records, showed that
the incidence ratio for women vs. men for asthma hospi-
talization reached 2.8 for individuals 25e34 years of age,
decreased gradually with increasing age, and then
approached unity for those aged 80 years or more.29
Contrary to that observed by others who reported that
men would have a higher risk of COPD than women in the
younger age groups (45e49 years, 50e54 years) and women
would show a higher risk in the older age groups up to the
75e79 years,30 in our population the risk of COPD was
always higher in men than in women regardless of age.
In conclusion, our findings show that the prevalence of
asthma is higher than that of COPD in an adult Italian general
population with higher prevalence of asthma in women and
higher prevalence of COPD in men. It is important to stressthat this information comes from an administrative health
database. We believe databases provide a valuable method
for identifying sex differences in the epidemiology of asthma
and COPD, because they provide large sample sizes, have
strong statistical power, are relatively inexpensive studies to
conduct, and can link information on diagnosis, and treat-
ment. An administrative health database may represent the
‘real world’ more accurately and characterize sex differ-
ences more fully than do other data sources.
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